Research graph
References from Nucleolin Alterations and ROS Production Associate With Sensitivity of AML Cells to Venetoclax. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.blre.2025.101288
10.1016/j.blre.2025.101288 · External reference
10.1182/blood.2022016867
10.1182/blood.2022016867 · External reference
10.1038/s41375‐025‐02531‐8
10.1038/s41375‐025‐02531‐8 · External reference
10.1177/10781552251396885
10.1177/10781552251396885 · External reference
10.1186/s13045‐015‐0224‐3
10.1186/s13045‐015‐0224‐3 · External reference
10.1016/s1470‐2045(24)00070‐6
10.1016/s1470‐2045(24)00070‐6 · External reference
10.1080/14656566.2023.2218545
10.1080/14656566.2023.2218545 · External reference
10.1182/blood‐2018‐08‐868752
10.1182/blood‐2018‐08‐868752 · External reference
10.1002/cncr.35806
10.1002/cncr.35806 · External reference
10.1038/s41408‐025‐01346‐1
10.1038/s41408‐025‐01346‐1 · External reference
10.1182/blood.2020006785
10.1182/blood.2020006785 · External reference
10.1182/blood.2022017341
10.1182/blood.2022017341 · External reference
10.1016/j.bbadis.2025.168065
10.1016/j.bbadis.2025.168065 · External reference
10.1182/blood.2021014304
10.1182/blood.2021014304 · External reference
10.3390/ijms20236003
10.3390/ijms20236003 · External reference
10.1126/scisignal.abp9586
10.1126/scisignal.abp9586 · External reference
10.1155/2011/253529
10.1155/2011/253529 · External reference
10.1007/s00210‐025‐04054‐6
10.1007/s00210‐025‐04054‐6 · External reference
10.1182/blood.2020009081
10.1182/blood.2020009081 · External reference
10.1093/nar/gkaa1110
10.1093/nar/gkaa1110 · External reference
10.1038/sj.leu.2402090
10.1038/sj.leu.2402090 · External reference
10.1002/jcp.28091
10.1002/jcp.28091 · External reference
10.1139/cjpp‐2021‐0596
10.1139/cjpp‐2021‐0596 · External reference
10.3892/ijo.2020.5052
10.3892/ijo.2020.5052 · External reference
10.1038/emm.2006.63
10.1038/emm.2006.63 · External reference
10.1371/journal.pone.0238856
10.1371/journal.pone.0238856 · External reference
10.1038/s41418‐022‐00999‐w
10.1038/s41418‐022‐00999‐w · External reference
10.15698/cst2018.06.139
10.15698/cst2018.06.139 · External reference
10.1002/jcb.25420
10.1002/jcb.25420 · External reference
10.1139/bcb‐2016‐0068
10.1139/bcb‐2016‐0068 · External reference
Unresolved reference
2008 · External reference
10.1371/journal.pone.0109858
10.1371/journal.pone.0109858 · External reference
10.1091/mbc.e10‐07‐0599
10.1091/mbc.e10‐07‐0599 · External reference
10.1016/s0968‐4328(99)00068‐2
10.1016/s0968‐4328(99)00068‐2 · External reference
10.1371/journal.pone.0170160
10.1371/journal.pone.0170160 · External reference
10.1038/s41467‐018‐05557‐y
10.1038/s41467‐018‐05557‐y · External reference
10.1074/jbc.m109.098830
10.1074/jbc.m109.098830 · External reference
10.1182/blood‐2006‐08‐043257
10.1182/blood‐2006‐08‐043257 · External reference
10.1074/jbc.m608068200
10.1074/jbc.m608068200 · External reference
Both Carboxy‐Terminus NES Motif and Mutated Tryptophan(s) Are Crucial for Aberrant Nuclear Export of Nucleophosmin Leukemic Mutants in NPMc+ AML
10.1182/blood-2005-11-4745 · 2006 · External reference
10.1016/j.biocel.2018.08.008
10.1016/j.biocel.2018.08.008 · External reference
10.1007/s12032‐015‐0530‐1
10.1007/s12032‐015‐0530‐1 · External reference
10.1182/bloodadvances.2024012906
10.1182/bloodadvances.2024012906 · External reference
10.1056/nejmoa2012971
10.1056/nejmoa2012971 · External reference
10.1038/cr.2007.36
10.1038/cr.2007.36 · External reference
10.1182/blood‐2014‐03‐563296
10.1182/blood‐2014‐03‐563296 · External reference
10.1016/j.bbamcr.2023.119501
10.1016/j.bbamcr.2023.119501 · External reference
10.1038/s41375‐022‐01785‐w
10.1038/s41375‐022‐01785‐w · External reference
10.1111/bph.12243
10.1111/bph.12243 · External reference
10.1016/j.jid.2021.11.035
10.1016/j.jid.2021.11.035 · External reference
10.3390/ijms26209859
10.3390/ijms26209859 · External reference
10.1155/2013/659254
10.1155/2013/659254 · External reference
10.1158/1538‐7445.am2026‐1862
10.1158/1538‐7445.am2026‐1862 · External reference
10.1074/jbc.m309111200
10.1074/jbc.m309111200 · External reference
10.1152/ajpcell.00217.2011
10.1152/ajpcell.00217.2011 · External reference
10.1152/ajpregu.00299.2019
10.1152/ajpregu.00299.2019 · External reference
10.1038/s41416‐022‐02074‐0
10.1038/s41416‐022‐02074‐0 · External reference
10.1016/j.bbagen.2024.130602
10.1016/j.bbagen.2024.130602 · External reference
10.1158/1078‐0432.ccr‐13‐1453
10.1158/1078‐0432.ccr‐13‐1453 · External reference
10.3390/ijms222312635
10.3390/ijms222312635 · External reference
10.1016/j.pharmthera.2021.107916
10.1016/j.pharmthera.2021.107916 · External reference
10.1016/j.bbagrm.2024.195029
10.1016/j.bbagrm.2024.195029 · External reference
10.1093/nar/gkz1242
10.1093/nar/gkz1242 · External reference
10.1007/s13402‐023‐00837‐2
10.1007/s13402‐023‐00837‐2 · External reference
10.1080/15476286.2017.1408764
10.1080/15476286.2017.1408764 · External reference
10.1093/nar/gkq247
10.1093/nar/gkq247 · External reference
